In recent years, animal experiments have also proven that a decreased transcriptional expression of SLC10A2 leads to an increase in fecal bile acids and stimulates tumor promotion (Raufman et al., 2015; Aymeric et al., 2018). This evidence concerns the gene SLC10A2 and neoplasm.